Trabeculectomy or modified deep sclerectomy in juvenile uveitic glaucoma by Heinz, Carsten et al.
ORIGINAL RESEARCH
Trabeculectomy or modified deep sclerectomy in juvenile
uveitic glaucoma
Carsten Heinz & Jörg M. Koch & Arnd Heiligenhaus
Received: 12 July 2011 /Accepted: 18 August 2011 /Published online: 8 September 2011
# The Author(s) 2011. This article is published with open access at SpringerLink.com
Abstract
Purpose The purpose of this study is to report the
effectiveness of trabeculectomies (TE) and modified deep
sclerectomies (mdS) in a group of patients with juvenile
uveitic secondary glaucoma.
Methods This is a retrospective analysis of 16 TE and eight
mdS.
Results Postoperatively, an IOP reduction to 11.6±
4.7 mmHg was achieved in the TE group and to 18.5±
11.4 mmHg in the mdS group (p=0.045). In the TE group,
14 patients showed postoperative success, one limited
success and another was a failure compared to four
successes and four failures in the mdS group (p=0.041).
The mean number of complications was 1.25±1.49 in the
TE group and 0.38±0.74 after mdS (p=0.11). In the mdS
group, four patients (50%) needed additional glaucoma
surgery compared to one TE patient (p=0.023).
Conclusion Both surgical techniques showed a marked
reduction of IOP. Trabeculectomy has a higher probability




Management of secondary uveitic glaucoma in children can
be quite challenging. The reported incidence of glaucoma
in childhood uveitis varies profoundly in the literature, with
figures up to 35% [1–4]. Little data are available on the
success rates of topical therapy alone. In two studies on
eyes predominately with JIA-associated anterior uveitis,
17% and 26% of patients had controlled intraocular
pressure (IOP) with topical therapy alone [5, 6]. The rate
of surgery was also comparable with 63% and 59% in these
studies [5, 6]. No widely accepted recommended surgical
approach exists so far to treat this group of secondary
juvenile glaucoma patients. The aim of this study is to
compare success rates of two glaucoma filtering surgery
procedures, especially to examine the value of the non-
penetrating approach, in a group of juvenile uveitis patients
with secondary glaucoma. Secondary outcome measure was
the number of additional glaucoma surgery.
Patients and methods
All consecutive trabeculectomies (TE) or modified deep
sclerectomies (mdS) performed from 2001 to the end of
2009 in patients with uveitis with onset before the age of
16 years and secondary glaucoma were retrospectively
analysed. All patients underwent the surgical procedure
after topical and systemic antiglaucomatous medication
f a i l e dt op r e v e n ts u s t a i n e dI O Pa b o v e2 4m m H go r
following the detection of typical glaucomatous optic disc
morphology by funduscopy. The study design complies
with the Declaration of Helsinki ethical standards. Our
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DOI 10.1007/s12348-011-0039-5institutions do not need approval of the local ethics
committees for chart review studies. Uveitis was classified
according to the recommendations of the International
Uveitis Study Group and is also in accordance with the
recent modifications [7, 8].
Demographic data, anatomic classification, association
with uveitis, best corrected visual acuity, onset of uveitis and
the time at which glaucoma was diagnosed were recorded for
each patient. The presence of typical uveitis-related compli-
cations were documented, e.g. band keratopathy, cataract
formation, secondary glaucoma (presence of typical glaucom-
atous disc cupping as measured by biomicroscopy), posterior
synechies, vitreous opacities, macular oedema, ocular hypot-
ony, phthisis or retinal detachment. In addition, the number of
topical and systemic antiglaucomatous and immunosuppres-
sive medications administered was documented. In addition,
the numberofprevioussurgeries,especiallytransscleraldiode
cyclophotocoagulation (TDCPC), and lens status were eval-
uated. Assessment of IOP was done by Goldman applanation
tonometry after topical anaesthesia between 8 and 12 a.m.
Patients were also on their regular scheme for application of
IOP-reducing topical medications. Surgery was performed in
all patients after quiescence of inflammation was achieved for
at least 2 months. All patients received topical unpreserved
dexamethasone phosphate 1% eye drops five times daily for
1 week prior to surgery to reduce conjunctival inflammation
[9]. Topical and systemic antiglaucomatous medications had
to be continued until surgery due to the high range of IOP. In
children with bilateral secondary glaucoma, only the first
operated eye was included.
One surgeon performed all surgical procedures. In all of
these patients, the conjunctival area for bleb formation had
been omitted from TDCPC. Trabeculectomy was performed
in a standard fashion, with a fornix-based conjunctival and
limbus-based scleral flap (3×3 mm). Mitomycin C (0.2 mg/ml)
was applied to the bare sclera for 1 min before preparation of
the scleral flap. Trephination was performed with a 1.5-mm
trephine, followed by basal iridectomy. The sclera flap was
adjusted with four non-absorbable 10-0 nylon stitches, and
wound closure was performed in two layers with 10-0
polyglyctan sutures.
In modified sclerectomy, the conjunctiva was opened
fornix based with a 6-mm incision. Mitomycin C
(0.2 mg/ml) was applied on the bare sclera for 1 min
before preparation of the scleral flap. A limbus-based
scleral flap was prepared. Following this, a deep scleral
lamella with de-roofing of Schlemm's channel was
performed. In order to avoid vitreous prolapse, two
Table 1 Patient's demographics
JIA juvenile idiopathic arthritis,
TDCPC transscleral diode
cyclophotocoagulation, CAI car-
bonic anhydrase inhibitors, TE
trabeculectomy, mdS modified
deep sclerectomy
Demographics TE mdS p value
Number of patients 16 8
Gender
Female/male 14/2 5/3 0.37
Age in years
At time of surgery 13.6 11.9 0.8
At uveitis diagnosis 5.0 4.7 0.11
Follow-up (months) 21.5 29.4 0.21
Uveitis association
JIA 12 7
Herpetic keratouveitis 0 1








Aphakic 3 5 0.03
Current therapy
Topical glaucoma therapy (number of drugs) 3.31 3.38 0.8
Systemic immunosuppression 14 6 0.57
TDCPC 14 6 0.52
Systemic CAI 10 6 1
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channel into the anterior chamber, lateral to the sclerec-
tomy. The scleral flap was adjusted with non-absorbable
10-0 nylon stitches. The conjunctiva was closed with 10-0
polyglyctan sutures.
Following surgery, both groups were treated with
atropine 1%; prednisolone acetate 1% and gentamicin eye
drops. Topical and anti-inflammatory medication was
continued after surgery, and dosages were adapted to the
course of inflammation.
An IOP of 21 or lower without glaucoma medication
was defined as a success. An IOP of 21 or lower with a
requirement for antiglaucomatous medication was defined
as a limited success; all other IOPs were defined as failures.
An IOP of 6 mmHg and lower was also defined as failure.
A second IOP limit for definition of success was set at
15 mmHg as recommended by the World Glaucoma
Association [10]. Minimum follow-up time after surgery
was 12 months.
The Fisher's exact or chi-squared test was used for
categorical values of complications and the Student's t test
for linear values. Hazard ratio and logrank test were
calculated for the survival analysis. A significance level of
5% was used for all studies.
Results
A total of 16 TE and eight mdS were performed in children
(19 girls) with uveitis onset before the age of 16. Age at
time of surgery was 12.7±3.8 years, and follow-up took
place 25.1±13.2 months (range 12–74 months) after
surgery in the whole study population. The mean associa-
tion with juvenile idiopathic arthritis as an underlying
disease was 79% within the whole group. There were no
differences between the groups concerning the kind of
topical antiglaucomatous or immunosuppressive therapy
before surgery (Table 1). None of the patients had previous
filtering surgery or implantation of glaucoma drainage
devices in the past. Detailed information on medical and
surgical glaucoma treatment before study procedures is also
included in Table 1.
IOP before filtering surgery was similar in both
groups, with 28.3±5.7 mmHg in the TE group and
3 0 . 3 ± 6 . 3m m H gi nt h em d Sg r o u p( p=0.44). One year
postoperatively or at the date of failure, an IOP reduction
to 11.6±4.7 mmHg was achieved in the TE group and to
18.5±11.4 mmHg in the mdS group (p=0.045). Figure 1
shows the IOP values before surgery, 1 year after surgery
and at the last visit of patients without failure (≤21 mmHg
or below with or without medication) at the last visit. The
mean IOP for patients with a success or limited success
1 year after surgery and at the last visit were slightly
higher in the mdS group without significance (p=0.42and
at last visit p=0.36)
Success (limit IOP ≤21 mmHg) was achieved in 14
(88%) patients after TE as compared to 4 (50%) patients in
the mdS group at the last visit. Surgical failure was
observed in one patient (6%) from the TE group, and in
another four (50%) cases in the mdS group (p=0.041).
Success rate 1 year after surgery was comparable with
identical data in the TE group and five successes and three
failures in the mdS group (p=0.13) Using the more rigid
classification at the last visit with IOP ≤15 mmHg as limit,
12 (75%) TE patients achieved a success compared to 3
(38%) in the mdS group. Limited success was found in one
(6%) patient in the TE group, while three (19%) patients in
the TE group and five (63%) in the mdS group failed (p=
0.092). None of the patients failed due to hypotony (IOP
Fig. 1 Intraocular pressure before surgery (pre), 1 year after surgery
and at the last visit of patients without failure (limit ≤21 mmHg) at the
last visit. TE trabeculectomy (n=15), mdS modified deep sclerectomy
(n=4)
Table 2 Success rates after surgery, subgroups after lens status
Pearson and Fisher test, success IOP ≤21 mmHg without antiglau-
comatous therapy, limited success IOP ≤21 mmHg with antiglaucom-
atous therapy and failure all others
Number TE (16) mdS (8) p value
All Success 14 4
Limited success 1 0
Failure 1 4 0.041
Phakic Success 10 1
Limited success 1 0 1.0
Aphakic Success 2 3
Failure 1 2 1.0
Pseudophakic Success 2 0
Failure 0 2 0.33
TE trabeculectomy, mdS modified deep sclerectomy
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avascular blebs could be observed. Subgroup analysis of
success rate (IOP ≤21 mmHg) and lens status revealed are
presented in Table 2. All failures were JIA children and
were associated with profound subconjunctival scarring
after glaucoma surgery.
Figure 2 shows the survival rate for both IOP classi-
fications. Using the classification of an IOP of 15 mmHg or
below, four out of five failures occur in the mdS group
within the first year, while failures in the TE group are
distributed over the complete follow-up period. The hazard
ratio (HR) for the limit of 15 mmHg was 0.16 with a 95%
confidence interval (CI) of 0.033 to 0.766 (p=0.02 logrank
test). For the 21-mmHg limit, the HR was 0.08 with CI of
0.012 to 0.573 (p=0.01).
Visual acuity did not differ significantly between the two
groups before (LogMAR TE group 0.3±0.3 vs. mdS group
0.43±0.32; p=0.32) and after surgery (LogMAR TE group
0.38±0.35 vs. mdS group 0.6±0.32; p=0.14). Also the
number of uveitis relapses within the first year after surgery
did not differ between the two groups with six flares in the
TE and two flares in the mdS group (p=0.66). The mean
number of complications, including a prominent Tenon
cyst, a shallow anterior chamber, choroidal detachment
combined with hypotony, vitreous prolapse into the
trephination and papilloedema, was 1.25±1.49 in the TE
group and 0.38±0.74 in the mdS group (p=0.11). A
shallow anterior chamber and a choroidal detachment were
the most frequent complications in the TE group (Table 3).
Additional surgery after initial TE or mdS was dived into
limited surgical interventions to achieve controlled IOP or
in additional glaucoma procedures. In the TE group, limited
surgical interventions were necessary in eight (50%)
patients compared to none in the mdS group (p=0.022).
One of those needed another glaucoma procedure to
achieve IOP below 21 mmHg later on. In the mdS group,
the need for additional glaucoma surgery was 50% (four
patients, p=0.023; Table 4).
Discussion
At present, there is no generally accepted or recommended
universal surgical approach for the management of juvenile
uveitic secondary glaucoma. Surgical treatment modalities
include trabeculectomy with MMC, goniotomy, trabeculo-
dialysis implantation of drainage devices and cyclodestruc-
tive procedures. The success rates reported for these
techniques at the end of profoundly diverse follow-up
times vary between 60% and 90% [5, 11–14]. One study
focused on JRA patients, which is a high risk glaucoma
group comparable to our patients. In this group, which is
known for its high failure rate after surgery, conventional
filtering surgery was able to control IOP in 57%, while
trabeculectomy with MMC controlled IOP in the remaining
four cases [5]. Cyclodestructive procedures, such as trans-
scleral diode laser cyclophotocoagulation, proved ineffec-
tive as a primary surgical approach in JIA-associated uveitis
and secondary glaucoma as the success rate was only 32%
after 1 year [15].
The value of non-penetrating glaucoma surgery for the
management of uveitic glaucoma has only been described
in few reports on adult patients. Overall success rates
(complete and qualified success) range from 87% to 100%.
A favourable aspect of this technique is that complications
(in these cases, lens opacities, reversible hypotony,
hyphema and bleb encapsulation) occur infrequently [16–
18]. We used a slightly modified standard deep sclerectomy
Fig. 2 Kaplan–Meier survival
curve for IOP ≤21 mmHg (a)
and for IOP ≤15 mmHg (b)i n
the patients after trabeculectomy
(TE) and modified deep
sclerectomy (mdS)
Table 3 Number and type of complications in both groups
Complications TE mdS
Tenon cyst 1 1
Vitreous prolapse 2
a
Shallow anterior chamber 7 1




TE trabeculectomy, mdS modified deep sclerectomy
aBoth were aphakic
bNo proven association with surgical intervention
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combined it with circumscribed goniotomies to increase the
filtration. In order to minimize the risk of vitreous prolapse
under the flap in aphakic eyes, the incisions on the inner
wall of Schlemm's canal were placed at each side. We
speculated that this might prevent the need for subsequent
goniopuncture, a procedure commonly required after deep
sclerectomy [19]. Until now, no studies have been available
presenting data on non-penetrating glaucoma surgery and
standard trabeculectomy in uveitis patients, especially in
children. Souissi and co-workers have published their data
on deep sclerectomy and on trabeculectomy in two separate
papers in adults. Their groups consisted of 8 patients in the
paper on deep sclerectomy, and another 17 in the
trabeculectomy paper. Patients were aged 56.9 and
48.1 years, respectively. In the deep sclerectomy group,
the procedure was successful in 88% of the patients,
compared to 65% in the trabeculectomy group with a
follow-up of 42 and 52 months [18, 20].
As reported by others, aphakic children had a higher
failure rate after glaucoma surgery. In a group of patients
with different entities of juvenile glaucoma, the failure rate
after trabeculectomy with MMC in aphakic children was as
high as 60% [21]. Another study analysed the outcome after
goniotomies in chronic childhood uveitis. The success rate
was only 36% (4 eyes) in aphakic patients, while 86% (25
eyes) of the procedures were successful in the phakic group
[11]. In our retrospective setting, there has been a bias
towards a certain surgical technique, which also results in
uneven balance of our two groups. The aphakic children in
this series were treated more frequently with the modified
deep sclerectomy in order to avoid vitreous in the
trephination. We are aware that comparison of the two
reported groups is therefore limited in some aspects but still
allows comparison of different aspects of these two surgical
procedures.
One prospective randomized trial exists that compares
these two different surgical techniques in adults with
primary open angle or pseudoexfoliation glaucoma [22].
In this study, both techniques provided sufficient IOP
reduction without any statistical significant difference. In
another study by the same authors, trabeculectomy
appeared to be more suitable for higher IOP levels and
longer life expectancies than deep sclerectomies [23]. Our
results regarding IOP reduction in juvenile uveitic glaucoma
are in accordance with these previous observations, as
trabeculectomy with MMC was more effective than modified
deep sclerectomy with MMC.
The overall rate of additional surgery including limited
postoperative interventions and additional glaucoma sur-
gery was similar in both groups. In the mdS group, four
additional glaucoma procedures had to be performed
compared to one in the TE group, while in TE group, eight
patients needed limited surgical interventions to adjust IOP
to levels between 10 and 20, including downsizing of the
filtering bleb, suture lysis and needling procedure. Postop-
erative choroidal detachment and a shallow anterior
chamber occurred in as many as 50% of the patients with
TE. This hypotony is probably due to reduced aqueous
production and increased uveoscleral drainage because of
postoperative inflammation. It can be speculated that these
complications might have accelerated the development of
posterior synechies, cataract formation and macular abnor-
malities. Cataract surgery was necessary in 5 of 11 phakic
children in the TE group during follow-up (mdS group: 0 of
1 phakic patient required this treatment), but it is impossible
to say whether the cataract formation was induced through
surgery or inflammation. The vitreous prolapse that occurred
during the immediate postoperative period in two aphakic
eyes was unfortunate. However, after surgical removal of the
vitreous strands, the trephination hole was overt.
In summary, glaucoma surgery in children with second-
ary uveitic glaucoma still remains difficult. Our data
suggest that IOP can be sufficiently reduced using standard
trabeculectomy with MMC and deep sclerectomy with
MMC, but TE with MMC may be more effective. However,
Table 4 Numbers and type of
surgical interventions for pres-
sure control or additional glau-
coma surgery







TE mdS p value
Number of patients with no procedure 8 4
Number of patients with limited surgical interventions to achieve controlled IOP 8 0
Downsizing of filtering bleb 4 0.022
Suture lysis 1
Needling of Tenon cyst 1
Removal of vitreous strands 2
Number of patients with additional glaucoma operation 1 4
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both groups. For aphakic children, the modified sclerec-
tomy described earlier appears to be a good technique for
avoiding vitreous prolapse.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution and reproduction in any medium, provided the original
author(s) and source are credited.
References
1. Heiligenhaus A, Niewerth M, Ganser G, Heinz C, Minden K
(2007) Prevalence and complications of uveitis in juvenile
idiopathic arthritis in a population-based nation-wide study in
Germany: suggested modification of the current screening guide-
lines. Rheumatology (Oxford) 46(6):1015–1019
2. Heiligenhaus A, Niewerth M, Mingels A, Ganser G, Thon A,
Pleyer U, Greiner K, Minden K (2005) Epidemiology of uveitis in
juvenile idiopathic arthritis from a national paediatric rheumato-
logic and ophthalmologic database. Klin Monbl Augenheilkd 222
(12):993–1001
3. Mingels A, Hudde T, Heinz C, Heiligenhaus A (2005) Visusmin-
dernde Komplikationen bei Uveitis im Kindesalter. Ophthalmo-
loge 102(5):477–484
4. Sijssens KM, Rothova A, Berendschot TT, de Boer JH (2006)
Ocular hypertension and secondary glaucoma in children with
uveitis. Ophthalmology 113(5):859
5. Foster CS, Havrlikova K, Baltatzis S, Christen WG, Merayo-
Lloves J (2000) Secondary glaucoma in patients with juvenile
rheumatoid arthritis-associated iridocyclitis. Acta Ophthalmol
Scand 78(5):576–579
6. Heinz C, Koch JM, Zurek-Imhoff B, Heiligenhaus A (2009)
Prevalence of uveitic secondary glaucoma and success of
nonsurgical treatment in adults and children in a tertiary referral
center. Ocul Immunol Inflamm 17(4):243–248
7. Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization
of uveitis nomenclature for reporting clinical data. Results of the
First International Workshop. Am J Ophthalmol 140(3):509–516
8. Bloch-Michel E, Nussenblatt RB (1987) International Uveitis
Study Group recommendations for the evaluation of intraocular
inflammatory disease. Am J Ophthalmol 103(2):234–235
9. Broadway DC, Grierson I, Sturmer J, Hitchings RA (1996)
Reversal of topical antiglaucoma medication effects on the
conjunctiva. Arch Ophthalmol 114(3):262–267
10. Shaarawy TM, Sherwood MB, Grehn F (eds) (2009) Guidelines on
design and reporting of glaucoma surgical trials. Kugler, Amsterdam
11. Ho CL, Wong EY, Walton DS (2004) Goniosurgery for glaucoma
complicating chronic childhood uveitis. Arch Ophthalmol 122
(6):838–844
12. Kafkala C, Hynes A, Choi J, Topalkara A, Foster CS (2005)
Ahmed valve implantation for uncontrolled pediatric uveitic
glaucoma. J AAPOS 9(4):336–340
13. Kanski JJ, McAllister JA (1985) Trabeculodialysis for inflamma-
tory glaucoma in children and young adults. Ophthalmology 92
(7):927–930
14. Valimaki J, Airaksinen PJ, Tuulonen A (1997) Molteno implan-
tation for secondary glaucoma in juvenile rheumatoid arthritis.
Arch Ophthalmol 115(10):1253–1256
15. Heinz C, Koch JM, Heiligenhaus A (2006) Transscleral diode
laser cyclophotocoagulation as primary surgical treatment for
secondary glaucoma in juvenile idiopathic arthritis: high failure
rate after short term follow up. Br J Ophthalmol 90(6):737–740
16. Arruabarrena C, Munoz-Negrete FJ, Marquez C, Rebolleda G
(2007) Results of nonpenetrating deep sclerectomy in inflamma-
tory glaucoma: one year follow up. Arch Soc Esp Oftalmol 82
(8):483–487
17. Auer C, Mermoud A, Herbort CP (2004) Deep sclerectomy for the
management of uncontrolled uveitic glaucoma: preliminary data.
Klin Monbl Augenheilkd 221(5):339–342
18. Souissi K, El Afrit MA, Trojet S, Kraiem A (2006) Deep
sclerectomy for the management of uveitic glaucoma. J Fr
Ophtalmol 29(3):265–268
19. Moreno-Montanes J, Rebolleda G, Munoz-Negrete FJ (2007)
Prognostic value of gonioscopy after deep sclerectomy. Eur J
Ophthalmol 17(5):702–708
20. Souissi K, El Afrit MA, Trojet S, Kraiem A (2006) Trabeculec-
tomy for the management of uveitic glaucoma. J Fr Ophtalmol 29
(2):153–156
21. Beck AD, Wilson WR, Lynch MG, Lynn MJ, Noe R (1998)
Trabeculectomy with adjunctive mitomycin C in pediatric glaucoma.
Am J Ophthalmol 126(5):648–657
22. Cillino S, Di Pace F, Casuccio A, Lodato G (2005) Deep
sclerectomy versus punch trabeculectomy: effect of low-dosage
mitomycin C. Ophthalmologica 219(5):281–286
23. Cillino S, Di Pace F, Casuccio A, Calvaruso L, Morreale D, Vadala
M, Lodato G (2004) Deep sclerectomy versus punch trabeculec-
tomy with or without phacoemulsification: a randomized clinical
trial. J Glaucoma 13(6):500–506
170 J Ophthal Inflamm Infect (2011) 1:165–170